Apparent PKA activity responds to intermittent hypoxia in bone cells: a redox pathway?
We studied hypoxia-induced dynamic changes in the balance between PKA and PKA-counteracting phosphatases in the microfluidic environment in single cells using picosecond fluorescence spectroscopy and intramolecular fluorescence resonance energy transfer (FRET)-based sensors of PKA activity. First, we found that the apparent PKA activity in bone cells (MC3T3-E1 cells) and endothelial cells (bovine aortic endothelial cells) is rapidly and sensitively modulated by the level of O(2) in the media. When the O(2) concentration in the glucose-containing media was lowered due to O(2) consumption by the cells in the microfluidic chamber, the apparent PKA activity increases; the reoxygenation of cells under hypoxia leads to a rapid ( approximately 2 min) decrease of the apparent PKA activity. Second, lack of glucose in the media led to a lower apparent PKA activity and to a reversal of the response of the apparent PKA activity to hypoxia and reoxygenation. Third, the apparent PKA activity in cells under hypoxia was predominantly regulated via a cAMP-independent pathway since 1) changes in the cAMP level in the cells were not detected using a cAMP FRET sensor, 2) the decay of cAMP levels was too slow to account for the fast decrease in PKA activity levels in response to reoxygenation, and 3) the response of the apparent PKA activity due to hypoxia/reoxygenation was not affected by an adenylate cyclase inhibitor (MDL-12,330A) at 1 mM concentration. Fourth, the immediate onset of ROS accumulation in MC3T3-E1 cells subjected to hypoxia and the sensitivity of the apparent PKA activity to redox levels suggest that the apparent PKA activity change during hypoxia and reoxygenation in this study can be linked to a redox potential change in response to intermittent hypoxia through the regulation of activities of PKA-counteracting phosphatases such as protein phosphatase 1. Finally, our results suggest that the detection of PKA activity could be used to monitor responses of cells to hypoxia in real time.
Zhang
Yan-Liang
YL
La Jolla Bioengineering Institute, 505 Coast Blvd. S., La Jolla, CA 92037, USA.
Tavakoli
Hesam
H
Chachisvilis
Mirianas
M
D016475:3T3 Cells; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D015374:Biosensing Techniques; D002417:Cattle; D015687:Cell Hypoxia; D003035:Cobalt / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000235:genetics / Q000378:metabolism*; D042783:Endothelial Cells / Q000201:enzymology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D031541:Fluorescence Resonance Energy Transfer; D005947:Glucose / Q000172:deficiency; D007097:Imines / Q000494:pharmacology; D051379:Mice; D044085:Microfluidics; D010006:Osteoblasts / Q000187:drug effects / Q000201:enzymology*; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010766:Phosphorylation; D011714:Pyrans / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D013141:Spiro Compounds / Q000494:pharmacology; D013314:Stress, Mechanical; D013997:Time Factors; D014162:Transfection
D000067956:Adenylyl Cyclase Inhibitors; D004791:Enzyme Inhibitors; D007097:Imines; D011714:Pyrans; D017382:Reactive Oxygen Species; D013141:Spiro Compounds; C053079:tautomycin; D003035:Cobalt; C014925:RMI 12330A; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases; D010749:Phosphoprotein Phosphatases; D000262:Adenylyl Cyclases; C018021:cobaltous chloride; D005947:Glucose; D010100:Oxygen
Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16513-8
15545605
Mol Chem Neuropathol. 1998 Feb;33(2):113-24
9565969
Neuroscientist. 2008 Dec;14(6):626-36
19029060
Annu Rev Med. 1991;42:225-46
2035969
Nat Methods. 2008 Jan;5(1):29-36
18165805
N Engl J Med. 2005 Nov 10;353(19):2042-55
16282179
Prog Biophys Mol Biol. 2006 Jul;91(3):249-86
16137743
Essays Biochem. 2007;43:91-104
17705795
Sci STKE. 2002 Aug 20;2002(146):re11
12189251
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11715-20
9751731
Ann N Y Acad Sci. 2002 Jun;968:256-70
12119281
Physiology (Bethesda). 2006 Apr;21:86-92
16565474
Biol Signals Recept. 1999 Nov-Dec;8(6):366-74
10592379
Microcirculation. 2007 Feb;14(2):125-36
17365667
Am J Physiol Cell Physiol. 2008 Jul;295(1):C180-91
18480296
Annu Rev Physiol. 1995;57:311-32
7778871
Nature. 1999 Jun 10;399(6736):601-5
10376603
Free Radic Res. 2006 Aug;40(8):847-56
17015263
J Bone Miner Metab. 2007;25(5):266-76
17704991
Ann N Y Acad Sci. 2002 Oct;971:379-88
12438156
Mol Cell. 1999 Apr;3(4):413-22
10230394
Endocr Pathol. 2003 Winter;14(4):277-91
14739486
J Biol Chem. 2007 Jul 27;282(30):22072-9
17548350
J Biol Chem. 2008 Feb 1;283(5):2949-61
18045878
Brain Cell Biol. 2008 Aug;36(1-4):3-17
18941898
FASEB J. 2001 May;15(7):1312-4
11344124
Biochim Biophys Acta. 1977 Oct 13;484(2):465-75
911855
J Appl Physiol (1985). 2003 Aug;95(2):536-44
12692140
J Biol Chem. 2002 Nov 8;277(45):43505-11
12189155
Am J Physiol Cell Physiol. 2003 Sep;285(3):C499-508
12900384
Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1037-43
15205181
J Vasc Res. 2006;43(3):251-69
16491020
J Appl Physiol (1985). 2007 Jun;102(6):2379-88
17289907
Pflugers Arch. 1996 Nov-Dec;433(1-2):129-35
9019713
FASEB J. 2005 Oct;19(12):1725-7
16037099
BMC Neurosci. 2001;2:17
11716788
J Physiol. 1998 Oct 15;512 ( Pt 2):351-63
9763626
J Biol Chem. 2006 Jan 27;281(4):2061-70
16303765
J Appl Physiol (1985). 2005 Jan;98(1):404-14
15591310
Biochim Biophys Acta. 2007 Oct;1773(10):1558-71
17662481
Biochim Biophys Acta. 2008 Jan;1777(1):1-14
18036551
Circ Res. 2005 Dec 9;97(12):1236-44
16284184
Free Radic Biol Med. 2005 Jan 1;38(1):2-11
15589366
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):349-54
15630084
J Appl Physiol (1985). 2006 Sep;101(3):995-8; discussion 998
16902070
Biochem Biophys Res Commun. 2006 Sep 22;348(2):716-21
16895723
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):776-82
17272757
Biochem Biophys Res Commun. 2002 Sep 13;297(1):46-51
12220506
J Neurosci. 2006 Dec 6;26(49):12807-15
17151284
Methods Enzymol. 2007;435:199-218
17998056
Ann N Y Acad Sci. 2007 Nov;1117:1-11
18056033
FEBS J. 2007 Jul;274(13):3210-7
17565598
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15463-8
17030791
Curr Opin Crit Care. 2002 Jun;8(3):242-50
12386504
J Biol Chem. 2002 Feb 1;277(5):3388-96
11729190
Novartis Found Symp. 2006;272:157-71; discussion 171-5, 214-7
16686435
J Biol Chem. 2005 Jan 28;280(4):2750-8
15533936
Clin Orthop Relat Res. 1997 May;(338):247-52
9170387
Kidney Int. 1997 Feb;51(2):564-6
9027740
J Appl Physiol (1985). 2006 Sep;101(3):993-5; discussion 999
16675614
Circ Res. 1995 Oct;77(4):710-7
7554117
Biochem Biophys Res Commun. 1998 Jan 6;242(1):61-6
9439610
ACS Chem Biol. 2009 Sep 18;4(9):783-99
19645509